Functional bowel disorders: Should we try to understand and treat without curing?;Troubles fonctionnels intestinaux: Soigner sans comprendre et traiter sans queérir?

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 3 I, 2003, Pages 263-264

  Bergmann, Jean François ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SPASMOLYTIC AGENT;

CLINICAL TRIAL; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; EDITORIAL; HUMAN; INTESTINE ENDOSCOPY; META ANALYSIS; MORTALITY; PRESCRIPTION;

CAUSALITY; COLONIC DISEASES, FUNCTIONAL; EVIDENCE-BASED MEDICINE; GASTROENTEROLOGY; HUMANS; PALLIATIVE CARE; REMISSION INDUCTION;

EID: 0037365365     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. De Ponti F, Malagelada JR. Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharmacol Ther 1998;80:49-88.
2. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997;112:2120-37.
3. Dapoigny M, Dyard F, Grimaud JC, Guyot P, Van Ganse E. Troubles fonctionnels intestinaux et consommation de soins. Étude observationnelle en gastro-entérologie libérale. Gastroenterol Clin Biol 2003;27:265-71.
4. Chassany O, Marquis P, Scherrer B, Read NW, Finger T, Bergmann JF, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 1999;44:527-33.
5. Mayer EA, Thompson WG, Dent J. Irritable bowel syndrome: diagnosis, subgrouping, management, and clinical trial design. Introduction. Am J Med 1999;107:1S-4S.
6. Farthing MJ. New drugs in the management of the irritable bowel syndrome. Drugs 1998;56:11-21.
7. Poynard T, Naveau S, Mory B, Chaput JC. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994;8:499-510.
8. Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988;95:232-41.
9. Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45(Suppl 2):II69-77.
10. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999;45(Suppl 2):II1-5.
11. Committee for proprietary medicinal products. Points to consider on the evaluation of medicinal products for the treatment of irritable bowel syndrome. 2002, CPMP/EWP/785/97.